Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ACADEMIA
ACADEMIA
- Whistle-Blower Insists There Were Willful Data Falsifications in J-ADNI Project
July 9, 2014
- NCC Sets Up Rare Cancer Center, Eying Clinical Studies
July 1, 2014
- University of Tokyo Admits Inappropriate Patient Data Corrections in J-ADNI
June 25, 2014
- Univ. Says Data Leaks in SIGN Run Afoul of Personal Information Law, Newly Finds Bristol’s Misconduct
June 25, 2014
- Once-Weekly Trelagliptin Shows Non-Inferiority to Once-Daily Alogliptin in PIII Study
June 24, 2014
- National University Hospital Council Announces Guidelines on Disclosure of Funding
June 23, 2014
- Joint Committee Organized by Four Scientific Societies Urges Caution in the Use of Diamox as a Reagent
June 23, 2014
- Hokkaido University to Begin Clinical Study of Novel Cancer Diagnostic Imaging Agent
June 23, 2014
- Kitasato Univ. Doctor Urges Psychiatry Society to Create Penalties on Undeclared COI
June 13, 2014
- Acofide Shows Repeated Difference against Placebo in Controlled Studies: Prof. Miwa of Hyogo College of Medicine
June 10, 2014
- JSH’s Committee Calls for Guidelines to Clarify Relations Between Companies, Research Institutions
June 3, 2014
- VART Study Lead Investigator to Discuss with Co-Authors, Mull Paper Retractions
May 28, 2014
- Eisai Responds to Media Report of Allegations of Data Falsification in J-ADNI Study
May 28, 2014
- Chiba Univ. Advises Authors to Withdraw VART Papers
May 26, 2014
- Sapporo Hospital Sorry for Ethical Guidelines Violations in Nesp Clinical Study
May 19, 2014
- Chiba University Hospital Suspends Use of Novartis’s Products in Response to Scandal over VART Study
May 12, 2014
- Careful Approach Needed in Legislating for Clinical Research: JAMS Pres.
May 8, 2014
- VART Lead Investigator “Wants to Seriously Take University Advice” on Retracting Diovan Papers
May 2, 2014
- Claims of Superior Cardiorenal Protective Effects of Diovan “Cannot Be Supported”: Outside Investigation of VART Study
April 30, 2014
- Chiba University to Advise Researchers to Retract Diovan Papers
April 28, 2014
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…